Created at Source Raw Value Validated value
Sept. 21, 2021, 5:30 a.m. usa

[{"arm_notes": "nan", "treatment_id": null, "treatment_name": "AstraZeneca ChAdOx1 AZD1222 vaccine (AZ) full dose;AstraZeneca ChAdOx1 AZD1222 vaccine (AZ) half dose;Pfizer/BioNTech BNT162b2 vaccine (PF) full dose;Pfizer/BioNTech BNT162b2 vaccine (PF) half dose", "treatment_type": "Biological;Biological;Biological;Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "AstraZeneca ChAdOx1 AZD1222 vaccine (AZ) full dose;AstraZeneca ChAdOx1 AZD1222 vaccine (AZ) half dose;Pfizer/BioNTech BNT162b2 vaccine (PF) full dose;Pfizer/BioNTech BNT162b2 vaccine (PF) half dose", "treatment_type": "Biological;Biological;Biological;Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "AstraZeneca ChAdOx1 AZD1222 vaccine (AZ) full dose;AstraZeneca ChAdOx1 AZD1222 vaccine (AZ) half dose;Pfizer/BioNTech BNT162b2 vaccine (PF) full dose;Pfizer/BioNTech BNT162b2 vaccine (PF) half dose", "treatment_type": "Biological;Biological;Biological;Biological", "pharmacological_treatment": "Non pharmacological treatment"}]

[{"arm_notes": "full dose vs half dose booster;IM;already received two doses of Sinovac Inactivated COVID-19 vaccine (60 to less than 90 days)", "treatment_id": 161, "treatment_name": "Chadox1 ncov-19", "treatment_type": "Non replicating viral vector", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "full dose vs half dose booster;IM;already received two doses of Sinovac Inactivated COVID-19 vaccine (60 to less than 90 days)", "treatment_id": 222, "treatment_name": "Bnt162b2", "treatment_type": "Rna based vaccine", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "full dose vs half dose booster;IM;already received two doses of Sinovac Inactivated COVID-19 vaccine (90 to less than 120 days)", "treatment_id": 161, "treatment_name": "Chadox1 ncov-19", "treatment_type": "Non replicating viral vector", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "full dose vs half dose booster;IM;already received two doses of Sinovac Inactivated COVID-19 vaccine (90 to less than 120 days)", "treatment_id": 222, "treatment_name": "Bnt162b2", "treatment_type": "Rna based vaccine", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "full dose vs half dose booster;IM;already received two doses of Sinovac Inactivated COVID-19 vaccine (120 to less than 180 days)", "treatment_id": 161, "treatment_name": "Chadox1 ncov-19", "treatment_type": "Non replicating viral vector", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "full dose vs half dose booster;IM;already received two doses of Sinovac Inactivated COVID-19 vaccine (120 to less than 180 days)", "treatment_id": 222, "treatment_name": "Bnt162b2", "treatment_type": "Rna based vaccine", "pharmacological_treatment": "Vaccine"}]